Quick Answer
MiNK Therapeutics, Inc. reported Total Assets of $14.24 million for fiscal year 2025.
MiNK Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $14.24M | +148.9% |
| 2024 | $5.72M | +25.7% |
| 2023 | $4.55M | -78.8% |
| 2022 | $21.47M | -46.6% |
| 2021 | $40.24M | +783.4% |
| 2020 | $4.56M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $14.96M | +102.9% | +502.3% |
| June 30, 2025 | $2.48M | -75.9% | -41.8% |
| March 31, 2025 | $4.27M | -38.1% | -25.4% |
| December 31, 2024 | $5.72M | +25.7% | -22.4% |
| September 30, 2024 | $7.37M | -1.2% | -28.6% |
| June 30, 2024 | $10.32M | -14.8% | +49.7% |
| March 31, 2024 | $6.89M | -58.4% | +51.4% |
| December 31, 2023 | $4.55M | -78.8% | -39.0% |
- MiNK Therapeutics, Inc. showed an increase of +148.9% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, MiNK Therapeutics, Inc.’s total assets has grown by 212.6% (from $4.56 million to $14.24 million).
- The most recent figure is from MiNK Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: